3:27 PM
 | 
Nov 13, 2017
 |  BC Extra  |  Company News

Management tracks: PlaqueTec, Biohaven

Liquid biopsy play PlaqueTec Ltd. (Cambridge, U.K.) named Annalisa Jenkins CEO. She was president and CEO of Dimension Therapeutics Inc., which Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) acquired. Jenkins succeeds Tim Brears.

Neurology company Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) hired Scott Phillips as SVP of...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >